TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
MAZE

Maze Therapeutics, Inc.

Healthcare · Biotechnology · —

26.10$ -0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MAZE
Line item 2022 2023 2024 2025
– -52.3% +236.4% +65.1%
– -67.9% +491.2% +73.4%
– -70.8% +575.0% -3.8%
– -70.8% +575.0% +73.7%
– – – –
– +26.7% -29.0% -3.4%
– -21.5% +26.7% +9.1%
– +3.8% +3.2% +3.5%
– +27.4% -4.0% -7.5%
– – – –
– -90.1% +1,858.5% +80.3%
– – – –
– +0.0% +0.0% -1.9%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?